Probiotics showed the potential to reduce the serum concentration of IL-6, TNF-α, and hs-CRP, which are the major risk factors for inflammation-dependent metabolic diseases like type-2 diabetes. The gene discussed is TNF; the disease is type 2 diabetes mellitus.